Evofem stock surges 27% as Phexxi sales pick up Q/Q, net loss narrows; affirms outlook

Zerbor Evofem Biosciences (NASDAQ:EVFM) stock soared ~31% post market on Aug. 4 after Q2 net loss narrowed and the women health company reaffirmed its FY22 product sales outlook. Q2 net sales of birth control vaginal gel Phexxi grew +42% Q/Q to $6M. The company said the increase reflected higher ex-factory sales and lower gross-to-net adjustments … Read more

India’s April-June fiscal deficit narrows amid fall in subsidies

India’s fiscal deficit for the three months through June rose lower-than expected to Rs 3.5 trillion, helped by a lower spending on subsidies and higher tax collections, government data showed on Friday. Tax collections grew, partly due to higher inflation, helping the government collect more goods and services tax (GST), as well as higher corporate … Read more